Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
AstraZeneca PLC stock logo
AZN
AstraZeneca
$68.95
+2.0%
$71.15
$61.24
$87.68
$213.83B0.45.15 million shs7.05 million shs
Novartis AG stock logo
NVS
Novartis
$108.93
+0.2%
$110.19
$96.06
$120.92
$229.62B0.61.57 million shs3.42 million shs
Pfizer Inc. stock logo
PFE
Pfizer
$23.09
+3.6%
$23.96
$20.92
$31.54
$131.25B0.5840.67 million shs77.37 million shs
Thermo Fisher Scientific Inc. stock logo
TMO
Thermo Fisher Scientific
$432.16
+7.2%
$462.82
$401.75
$627.88
$163.14B0.821.81 million shs3.72 million shs
Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
AstraZeneca PLC stock logo
AZN
AstraZeneca
+2.04%-4.36%+4.01%-5.20%-10.66%
Novartis AG stock logo
NVS
Novartis
+0.23%-3.68%+1.29%+1.12%+6.69%
Pfizer Inc. stock logo
PFE
Pfizer
+3.61%-3.25%+5.47%-9.58%-17.58%
Thermo Fisher Scientific Inc. stock logo
TMO
Thermo Fisher Scientific
+7.26%+2.32%-1.31%-20.74%-27.13%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
AstraZeneca PLC stock logo
AZN
AstraZeneca
3.6958 of 5 stars
3.65.01.70.03.60.01.3
Novartis AG stock logo
NVS
Novartis
2.3273 of 5 stars
2.03.02.50.03.00.01.9
Pfizer Inc. stock logo
PFE
Pfizer
4.9993 of 5 stars
4.33.04.24.33.43.33.1
Thermo Fisher Scientific Inc. stock logo
TMO
Thermo Fisher Scientific
4.9388 of 5 stars
4.43.02.54.13.62.51.3
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
AstraZeneca PLC stock logo
AZN
AstraZeneca
3.10
Buy$88.0027.63% Upside
Novartis AG stock logo
NVS
Novartis
2.00
Hold$123.3813.26% Upside
Pfizer Inc. stock logo
PFE
Pfizer
2.53
Moderate Buy$29.1726.34% Upside
Thermo Fisher Scientific Inc. stock logo
TMO
Thermo Fisher Scientific
2.81
Moderate Buy$607.4340.56% Upside

Current Analyst Ratings Breakdown

Latest TMO, AZN, PFE, and NVS Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
4/30/2025
Pfizer Inc. stock logo
PFE
Pfizer
UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetNeutral ➝ Neutral$24.00 ➝ $25.00
4/29/2025
Thermo Fisher Scientific Inc. stock logo
TMO
Thermo Fisher Scientific
Argus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$620.00 ➝ $470.00
4/25/2025
Thermo Fisher Scientific Inc. stock logo
TMO
Thermo Fisher Scientific
Scotiabank
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetSector Perform ➝ Sector Perform$650.00 ➝ $605.00
4/24/2025
Thermo Fisher Scientific Inc. stock logo
TMO
Thermo Fisher Scientific
Royal Bank of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOutperform ➝ Outperform$651.00 ➝ $637.00
4/24/2025
Thermo Fisher Scientific Inc. stock logo
TMO
Thermo Fisher Scientific
UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$715.00 ➝ $500.00
4/24/2025
Thermo Fisher Scientific Inc. stock logo
TMO
Thermo Fisher Scientific
Stifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$665.00 ➝ $620.00
4/24/2025
Thermo Fisher Scientific Inc. stock logo
TMO
Thermo Fisher Scientific
Evercore ISI
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOutperform ➝ Outperform$585.00 ➝ $500.00
4/24/2025
Thermo Fisher Scientific Inc. stock logo
TMO
Thermo Fisher Scientific
Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOverweight ➝ Overweight$580.00 ➝ $570.00
4/24/2025
Thermo Fisher Scientific Inc. stock logo
TMO
Thermo Fisher Scientific
Robert W. Baird
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOutperform ➝ Outperform$603.00 ➝ $573.00
4/23/2025
Thermo Fisher Scientific Inc. stock logo
TMO
Thermo Fisher Scientific
The Goldman Sachs Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Set Price TargetBuy ➝ Buy$610.00
4/22/2025
Pfizer Inc. stock logo
PFE
Pfizer
Cantor Fitzgerald
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageOverweight ➝ Neutral$24.00
(Data available from 5/13/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
AstraZeneca PLC stock logo
AZN
AstraZeneca
$54.98B3.89$5.85 per share11.79$13.18 per share5.23
Novartis AG stock logo
NVS
Novartis
$53.22B4.32$10.86 per share10.03$21.59 per share5.05
Pfizer Inc. stock logo
PFE
Pfizer
$62.46B2.10$3.62 per share6.38$15.81 per share1.46
Thermo Fisher Scientific Inc. stock logo
TMO
Thermo Fisher Scientific
$42.90B3.80$24.13 per share17.91$129.54 per share3.34
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
AstraZeneca PLC stock logo
AZN
AstraZeneca
$7.04B$2.4930.5113.791.4213.01%32.23%12.31%7/24/2025 (Estimated)
Novartis AG stock logo
NVS
Novartis
$11.94B$6.4018.5312.361.7023.56%37.24%15.85%7/17/2025 (Estimated)
Pfizer Inc. stock logo
PFE
Pfizer
$8.03B$1.3816.377.620.6412.62%19.47%8.09%7/29/2025 (Estimated)
Thermo Fisher Scientific Inc. stock logo
TMO
Thermo Fisher Scientific
$6.34B$17.0526.1416.912.9914.78%17.51%8.52%7/23/2025 (Estimated)

Latest TMO, AZN, PFE, and NVS Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
4/29/2025Q1 2025
AstraZeneca PLC stock logo
AZN
AstraZeneca
$1.10$1.24+$0.14$0.93$13.71 billion$13.59 billion
4/29/2025Q1 2025
Novartis AG stock logo
NVS
Novartis
$2.12$2.28+$0.16$1.83$12.92 billion$13.23 billion
4/29/2025Q1 2025
Pfizer Inc. stock logo
PFE
Pfizer
$0.67$0.92+$0.25$0.52$14.43 billion$13.72 billion
4/23/2025Q1 2025
Thermo Fisher Scientific Inc. stock logo
TMO
Thermo Fisher Scientific
$5.10$5.15+$0.05$3.98$10.23 billion$10.36 billion
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
AstraZeneca PLC stock logo
AZN
AstraZeneca
$2.062.99%+1.98%82.73%N/A
Novartis AG stock logo
NVS
Novartis
$2.592.38%+5.34%40.47%N/A
Pfizer Inc. stock logo
PFE
Pfizer
$1.727.45%+2.50%124.64%16 Years
Thermo Fisher Scientific Inc. stock logo
TMO
Thermo Fisher Scientific
$1.720.40%+14.47%10.09%8 Years

Latest TMO, AZN, PFE, and NVS Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
4/23/2025
Pfizer Inc. stock logo
PFE
Pfizer
quarterly$0.437.69%5/9/20255/9/20256/13/2025
2/19/2025
Thermo Fisher Scientific Inc. stock logo
TMO
Thermo Fisher Scientific
quarterly$0.430.32%3/14/20253/14/20254/15/2025
2/20/2025
Novartis AG stock logo
NVS
Novartis
$3.86953/12/20253/12/20253/12/2025
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
AstraZeneca PLC stock logo
AZN
AstraZeneca
0.65
0.93
0.74
Novartis AG stock logo
NVS
Novartis
0.48
1.04
0.84
Pfizer Inc. stock logo
PFE
Pfizer
0.63
1.00
0.73
Thermo Fisher Scientific Inc. stock logo
TMO
Thermo Fisher Scientific
0.59
1.66
1.29

Institutional Ownership

CompanyInstitutional Ownership
AstraZeneca PLC stock logo
AZN
AstraZeneca
20.35%
Novartis AG stock logo
NVS
Novartis
13.12%
Pfizer Inc. stock logo
PFE
Pfizer
68.36%
Thermo Fisher Scientific Inc. stock logo
TMO
Thermo Fisher Scientific
89.23%

Insider Ownership

CompanyInsider Ownership
AstraZeneca PLC stock logo
AZN
AstraZeneca
N/A
Novartis AG stock logo
NVS
Novartis
0.01%
Pfizer Inc. stock logo
PFE
Pfizer
0.06%
Thermo Fisher Scientific Inc. stock logo
TMO
Thermo Fisher Scientific
0.33%
CompanyEmployeesShares OutstandingFree FloatOptionable
AstraZeneca PLC stock logo
AZN
AstraZeneca
83,5003.10 billionN/AOptionable
Novartis AG stock logo
NVS
Novartis
101,7002.11 billion2.04 billionOptionable
Pfizer Inc. stock logo
PFE
Pfizer
83,0005.69 billion5.66 billionOptionable
Thermo Fisher Scientific Inc. stock logo
TMO
Thermo Fisher Scientific
130,000377.49 million381.20 millionOptionable

Recent News About These Companies

Thermo Fisher: Tariffs Hit, Valuation Compensates

New MarketBeat Followers Over Time

Media Sentiment Over Time

AstraZeneca stock logo

AstraZeneca NASDAQ:AZN

$68.95 +1.38 (+2.04%)
Closing price 05/12/2025 04:00 PM Eastern
Extended Trading
$68.70 -0.25 (-0.36%)
As of 05/12/2025 08:00 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacture, and commercialization of prescription medicines. The company's marketed products include Tagrisso, Imfinzi, Lynparza, Calquence, Enhertu, Orpathys, Truqap, Zoladex, Faslodex, Farxiga, Brilinta, Lokelma, Roxadustat, Andexxa, Crestor, Seloken, Onglyza, Bydureon, Fasenra, Breztri, Symbicort, Saphnelo, Tezspire, Pulmicort, Bevespi, and Daliresp for cardiovascular, renal, metabolism, and oncology. Its marketed products also comprise Vaxzevria, Beyfortus, Synagis, FluMist, Soliris, Ultomiris, Strensiq, Koselugo, and Kanuma for covid-19 and rare disease. The company serves primary care and specialty care physicians through distributors and local representative offices in the United Kingdom, rest of Europe, the Americas, Asia, Africa, and Australasia. It has a collaboration agreement with Neurimmune AG to develop and commercialize NI006; BenevolentAI for drug discovery for systemic lupus erythematosus; and Absci Corporation for AI-driven drug discovery against an oncology target. The company was formerly known as Zeneca Group PLC and changed its name to AstraZeneca PLC in April 1999. AstraZeneca PLC was incorporated in 1992 and is headquartered in Cambridge, the United Kingdom.

Novartis stock logo

Novartis NYSE:NVS

$108.93 +0.23 (+0.21%)
Closing price 05/12/2025 03:59 PM Eastern
Extended Trading
$109.28 +0.35 (+0.32%)
As of 05/12/2025 07:42 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Novartis AG engages in the research, development, manufacture, and marketing of healthcare products in Switzerland and internationally. The company offers prescription medicines for patients and physicians. It focuses on therapeutic areas, such as cardiovascular, renal and metabolic, immunology, neuroscience, and oncology, as well as ophthalmology and hematology. Novartis AG has a license and collaboration agreement with Alnylam Pharmaceuticals to develop, manufacture, and commercialize inclisiran, a therapy to reduce LDL cholesterol; and Dawn Health for the development and commercialization of Ekiva, a digital solution designed for people living with Paroxysmal Nocturnal Hemoglobinuria. The company was incorporated in 1996 and is headquartered in Basel, Switzerland.

Pfizer stock logo

Pfizer NYSE:PFE

$23.08 +0.81 (+3.61%)
Closing price 05/12/2025 03:59 PM Eastern
Extended Trading
$22.93 -0.16 (-0.67%)
As of 05/12/2025 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States, Europe, and internationally. The company offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic, migraine, and women's health under the Eliquis, Nurtec ODT/Vydura, Zavzpret, and the Premarin family brands; infectious diseases with unmet medical needs under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and COVID-19 prevention and treatment, and potential future mRNA and antiviral products under the Comirnaty and Paxlovid brands. It also provides medicines and vaccines in various therapeutic areas, such as biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Litfulo, Velsipity, and Cibinqo brands; amyloidosis, hemophilia, endocrine diseases, and sickle cell disease under the Vyndaqel family, Oxbryta, BeneFIX, Somavert, Ngenla, and Genotropin brands; sterile injectable and anti-infective medicines under the Sulperazon, Medrol, Zavicefta, Zithromax, and Panzyga brands; and biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Inlyta, Bosulif, Mektovi, Padcev, Adcetris, Talzenna, Tukysa, Elrexfio, Tivdak, Lorbrena, and Braftovi brands. In addition, the company involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, individual provider offices, retail pharmacies, and integrated delivery systems. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Merck KGaA; and BioNTech SE. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.

Thermo Fisher Scientific stock logo

Thermo Fisher Scientific NYSE:TMO

$432.16 +29.03 (+7.20%)
Closing price 05/12/2025 03:59 PM Eastern
Extended Trading
$435.11 +2.95 (+0.68%)
As of 05/12/2025 08:00 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases; and solutions include biosciences, genetic sciences, and bio production to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets. Its Analytical Instruments segment provides instruments, consumables, software, and services for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. The company's Specialty Diagnostics segment offers liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, as well as calibrators, controls, protein detection assays, and instruments; immunodiagnostics develops, manufactures and markets complete bloodtest systems to support the clinical diagnosis and monitoring of allergy, asthma and autoimmune diseases; dehydrated and prepared culture media, collection and transport systems, instrumentation, and consumables; human leukocyte antigen typing and testing for organ transplant market; and healthcare products. Its Laboratory Products and Biopharma Services segment provides laboratory products, research and safety market channel, and pharma services and clinical research. It offers products and services through a direct sales force, customer-service professionals, electronic commerce, and third-party distributors under Thermo Scientific; Applied Biosystems; Invitrogen; Fisher Scientific; Unity Lab Services; and Patheon and PPD. Thermo Fisher Scientific Inc. was founded in 1956 and is headquartered in Waltham, Massachusetts.